hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 23:05:59 - browse：422

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Congress must give Medicare recipients genetic counseling access

Wikipedia

WSS

ARCH Venture Partners is raising $3 billion for a life sciences fund

ARCH Venture Partners is raising $3 billion for a life sciences fund

Clinical trials must include more disabled people

Living with Hashimoto's and celiac disease, and med school, too

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Biden administration opens offers in Medicare drug price negotiations

leisure time

hotspot

focus

Medical records are filled with copy

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Tori Bowie and the unacceptable rates of Black maternal death

As Maui death toll rises, number of missing remains unclear

After affirmative action ruling, medical educators look to 'holistic review'

Lung cancer is America's deadliest cancer. Yet so few get screened

Tori Bowie and the unacceptable rates of Black maternal death

ProMED sees offers of support, but its future remains unclear

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Baltimore teen accused of firing into crowd during block party mass shooting

focus

Apple Vision Pro: A first look at health apps on the new VR headset

The boys, now 6, who are gene therapy’s ‘edge case’ problem

New details revealed about Purdue's marketing of OxyContin

Apple Vision Pro: A first look at health apps on the new VR headset

Liz Cheney makes 1st public comment since Trump's election interference indictments

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

focus

Wikipedia

entertainment

focus